谷氨酸酶 - 癌症治疗的潜在目标
Josephine Anthony1, Sureka Varalakshmi1, Ashok Kumar Sekar2
1Department of Research, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Chennai 600 078, Tamil Nadu, India.
BioMedicine
|June 28, 2024
概括
过度表达谷氨酸酶 (GLS1) 通过谷氨酸溶解促进癌症生长. 抑制GLS1会破坏癌细胞的存活和增殖,为癌症治疗提供一种潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 代谢途径 代谢途径
背景情况:
- 谷氨酸酶 (GLS) 的过度表达驱动癌症的进展和转移通过谷氨酸溶解.
- 癌细胞为生存和繁殖重新编程了谷氨胺代谢,GLS1是关键的异型.
- 谷氨胺代谢通过mTORC1与自有关,具有治疗点.
研究的目的:
- 审查谷氨酸酶在癌症中的作用.
- 为突出针对谷氨酸胺酶的当前治疗策略.
- 讨论正在进行的谷氨酸酶抑制剂临床试验.
主要方法:
- 关于谷氨酸酶,谷氨酸溶解和癌症研究的文献综述.
- 分析与谷氨胺代谢相关的信号通路和基因表达.
- 收集关于谷氨酸酶抑制剂及其临床应用的数据.
主要成果:
- 抑制谷氨酸酶会导致谷氨酸水平降低,氧化应激增加,癌细胞的亡.
- 特定的谷氨胺酶抑制剂 (例如,BPTES,CB-839) 在临床前研究中显示出有前途.
- 该审查发现,了解特定的信号基因和涉及的途径存在差距.
结论:
- 向谷氨酸酶,特别是GLS1,是癌症的一种有前途的治疗方法.
- 胺酶抑制剂可以通过诱导癌细胞死亡来作为预防性治疗.
- 需要进一步的研究来阐明最佳治疗策略的确切信号通路.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.2K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
